Teva Settles Suit Over Watson’s Generic LoSeasonique

Law360, New York (December 12, 2011, 1:51 PM EST) -- Teva Women’s Health Inc. on Thursday settled a patent infringement suit in New Jersey over Watson Pharmaceuticals Inc.’s bid to market a generic version of Teva’s oral contraceptive LoSeasonique.

U.S. District Judge Claire C. Cecchi signed off on a joint stipulation to dismiss the suit with prejudice, saying both parties had agreed to drop claims and counterclaims related to Watson’s plans to produce a generic version of LoSeasonique.

Under the provisions of the settlement agreement, Watson was able to launch its Amethia Lo tablets, the generic...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.